8 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... + Warfarin) Reference ... #DOAC #Dosing #Oral ... #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for appropriate dosing ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
►
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
bleeding risk during ... with patients’ preference ... DOAC, direct oral ... #Anticoagulation ... #Management #Hematology
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Perioperative Management ... patients on chronic anticoagulation ... direct acting oral ... clearance (calculated using ... Perioperative #Management
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
ANCA Vasculitis Management ... Algorithm - ACR ... High-Dose Daily Oral ... Options in Order of Preference ... ANCA #Vasculitis #Management
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
can occur after using ... steps involved in management ... #treatment #algorithm ... References: ... Management of malignant
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
sx overlap with normal ... Management during ... Avoid Warfarin and DOAC ... Management during ... Management during
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Build a regimen using ... comorbidities, and preferences ... five effective oral ... Tuberculosis #MDRTB #management ... #pharmacology #dosing